Thomas Harrer

Strong Cytotoxic T Cell and Weak Neutralizing Antibody Responses in a Subset of Persons with Stable Nonprogressing HIV Type 1 Infection

Thomas Harrer, Ellen G. Harrer, Spyros A. Kalams et al. · AIDS Research and Human Retroviruses · 1996 · 326 citations

Primary Immunodeficiency, Autoimmune Disease, Normal Cd4 Counts +15

Therapeutic Vaccination of HIV-1-Infected Patients on Haart with a Recombinant HIV-1 <i>Nef</i>-Expressing Mva: Safety, Immunogenicity and Influence on Viral Load during Treatment Interruption

Ellen G. Harrer, Michael Bäuerle, Barbara Ferstl et al. · Antiviral Therapy · 2005 · 103 citations · Full text

Vaccination, Therapeutic Vaccination, Human Retrovirus +14

Analysis of the Interaction of Ebola Virus Glycoprotein with DC‐SIGN (Dendritic Cell–Specific Intercellular Adhesion Molecule 3–Grabbing Nonintegrin) and Its Homologue DC‐SIGNR

Andrea Marzi, Peggy Möller, Sheri L. Hanna et al. · The Journal of Infectious Diseases · 2007 · 85 citations · Full text

Anti-TNF-refractory colitis after checkpoint inhibitor therapy: Possible role of CMV-mediated immunopathogenesis

Katharina Lankes, Gheorghe Hundorfean, Thomas Harrer et al. · OncoImmunology · 2016 · 85 citations · Full text

Cmv-mediated Immunopathogenesis, Immunology, Gastroenterology +16

Prolonged Clinical Remission of Patients with Severe Pemphigus upon Rapid Removal of Desmoglein-Reactive Autoantibodies by Immunoadsorption

Rüdiger Eming, Jürgen Rech, Sandra Barth et al. · Dermatology · 2006 · 63 citations